Overview of Drug-Receptor Interaction
In drug-receptor interaction, when a drug molecule comes face to face with a receptor, the reaction between the two will depend upon affinity and some conformational likeness.
This interaction entails the formation of various types of chemical bonds, including (ICVHH):
Ionic Bonding: Electrostatic attraction between positively and negatively charged ions.
Covalent Bonding: A stronger bond that involves the sharing of electrons between atoms, leading to a more permanent interaction.
Vander Waals Bonding: Weak attractions between molecules or parts of molecules caused by transient local partial charges.
Hydrogen Bonding: A specific type of dipole-dipole interaction between a hydrogen atom bonded to a highly electronegative atom and another electronegative atom.
Hydrophobic Bonding: Interactions that occur when non-polar molecules cluster together to avoid contact with polar environments, often seen in membrane receptors.
Depending upon the type of bond formed between the drug and the receptor, the interaction can either be reversible or irreversible.
Reversible Interactions:
Typically represented by Equation 1 (D + R ↔ DR), where the drug (D) binds to the receptor (R) forming a drug-receptor complex (DR) that can dissociate.
This makes reversible interactions ideal for therapeutic use, allowing for the drug's effect to be terminated once the drug is eliminated from the body.
Irreversible Interactions:
Represented by Equation 2 (D + R → DR), where the drug binds permanently to the receptor, often through covalent bonds.
This can lead to longer-acting effects, as seen with phenoxybenzamine, which irreversibly blocks alpha-1 adrenergic receptors and results in an effect lasting from 14 to 48 hours.
For instance, omeprazole interacts with the hydrogen-potassium adenosinetriphosphatase (H⁺, K⁺ - ATPase) enzyme system found at the secretory surface of parietal cells, leading to significant suppression of gastric acid production.
Notably, while the half-life of omeprazole is about 30 minutes to one hour in individuals with normal liver function (indicating quick elimination), normal gastric acid production can take approximately 96 hours to resume post-discontinuation of the drug due to its irreversible action.
Following the interaction between a drug and its receptor, it is essential to understand that a drug modifies rather than produces a new effect.
Receptors, by normal physiological function, react with endogenous compounds, leading to a physiological response.
For instance, when endogenous epinephrine binds to beta-1 adrenergic receptors in the heart, it results in an increased heart rate.
Similarly, when a drug interacts with the beta-1 receptors, depending on its nature, it can either increase heart rate (as with dobutamine, an agonist) or decrease it (as with metoprolol, an antagonist).
Types of Drugs based on Receptor Interaction
Agonists:
Drugs that activate receptors to produce a response.
Antagonists:
Drugs that bind to receptors without activating them, which prevents the receptor from interacting with its endogenous ligands.
Antagonists can be further classified as:
Competitive Antagonists: Compete with agonists for the same binding site on the receptor.
Non-competitive Antagonists: Bind to a different site on the receptor, altering the receptor's function regardless of whether the agonist is present.
It is also essential to delineate the types of antagonism that can occur:
Receptor Antagonism:
The drug binds to the receptor but does not elicit a response, blocking the action of agonists.
Neutralizing Antagonism:
This occurs when two substances cancel each other out, such as calcium carbonate neutralizing gastric acid.
Physiological Antagonism:
Where two drugs exert opposite effects through different receptors.
For example, epinephrine (increases blood pressure) versus histamine (decreases blood pressure) reacting on their respective receptors (adrenergic and histamine receptors).